In one nested case-control study of 41 Swedish men who developed breast cancer after treatment for prostate cancer, the risk was higher in men treated with oestrogen than in other survivors of prostate cancer.12 The risk of gynaecomastia and breast cancer coexists in high oestrogen states. We also referred to our institutional experience with gynaecomastia and male breast cancer. Although cancers are diagnosed in only about 1% of cases of male breast enlargement, practitioners may feel uncertain about how to differentiate gynaecomastia (benign breast enlargement) from malignancy and how to manage these disorders. Gynecomastia is the enlargement of male breast tissue caused by excessive growth of the breast gland. Testosterone also can be converted to oestradiol by the enzyme aromatase, found especially in adipose tissue. Testicular Leydig cells produce 95% of testosterone. Our PCT Stack includes everything needed for comprehensive estrogen management. Consider your genetic predisposition — family history of gyno or high estrogen sensitivity means more aggressive prevention. Post-surgery, maintain proper estrogen control to prevent recurrence. Indeed, trials revealed that testosterone is not effective compared with placebo. Because gynecomastia usually regresses spontaneously, if the appropriate work-up does not reveal any considerable underlying pathology, reassurance and periodic follow-up are recommended at 6-month intervals. Pseudogynecomastia and true gynecomastia can be differentiated by physical examination, as described above. However, the yield of cells taken in a gynecomastia biopsy is often insufficient, because gynecomastia is a predominantly fibrous lesion. Mammography (MMG) is the primary imaging method used when there is any suspicion of cancer. Lastly, lifestyle factors such as obesity or excessive alcohol consumption can also increase the risk of developing gynecomastia. In some cases, medical conditions or diseases may be responsible for gynecomastia. Understanding what gynecomastia is and its potential causes can help individuals seek appropriate medical advice and treatment options. Other factors such as certain medications, underlying medical conditions, or lifestyle choices may also contribute to its development. He developed more gynaecomastia (to 6 cm) and pain in his right breast. Primary hypogonadism can lead to decreased T production, compensatory LH increase, Leydig cell stimulation, the inhibition of 17, 20-lyase and 17-hydroxylase activities, elevated aromatization of T to E2 and finally an increase in the ratio of E2 to T. Patients who develop re-feeding gynecomastia are therefore often described to be undergoing a ‘second puberty’. In the lead re-feeding gonadotropins are increased, leading to T secretion and E2 production, which mimics normal puberty. Although pubertal gynecomastia typically regresses on its own, in rare cases it may persist, requiring treatment. What about surgery for the treatment of gynecomastia? What drugs are used for the treatment of gynecomastia? Measurement of hormone levels in the bloodstream may also be recommended in some cases. Gynecomastia is the presence of true breast (glandular) tissue, generally located around the nipple. Occasionally, when the condition develops in puberty and persists beyond two years, it is referred to as persistent pubertal gynecomastia. Losing weight, eating a healthy diet, and avoiding substances that contribute to hormonal imbalances can help reduce or prevent gynecomastia. The treatment approach depends on the severity of the condition and the underlying cause. For more severe cases, medical treatment or surgery may be necessary. Certain SSRI medications have been linked to gynecomastia. Malnourishment can cause gynecomastia due to decreased gonadotropin and T levels, coupled with normal production of estrogens (and their precursors) from the adrenal glands. Spironolactone is also used to treat cirrhotic patients, which can exacerbate the condition.11,15 Alcohol use can also disrupt the hypothalamic–pituitary–testicular axis, causing a decrease in serum T levels. Interestingly, more than half of the patients with persistent pubertal gynecomastia have a family history of the condition.
